Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Esteban

Showing results (41-50 of 256) with videos related to

Pageof 26
Sort By:
The Journal of Biological Chemistry|April 15, 2006
Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosisSusana Guerra, Luis A López-Fernández, María Angel García, et al.
Infection and Immunity|July 26, 2005
Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasisBlaise Dondji, Eva Pérez-Jimenez, Karen Goldsmith-Pestana, et al.
Journal of Virology|October 26, 2007
Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infectionsElena Domingo-Gil, Eva Pérez-Jiménez, Iván Ventoso, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 8, 2019
Pregestational body mass index, trimester-specific weight gain and total gestational weight gain: how do they influence perinatal outcomes?Isabel Gonzalez-Ballano, Ricardo Saviron-Cornudella, Luis Mariano Esteban, et al.
Plos One|February 3, 2015
Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigenMaria L Knudsen, Karl Ljungberg, Roger Tatoud, et al.
Plos One|July 9, 2010
Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigensJosé Luis Nájera, Carmen Elena Gómez, Juan García-Arriaza, et al.
Viruses|December 28, 2017
Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling PathwaysCarmen Elena Gómez, Beatriz Perdiguero, Cristina Sánchez-Corzo, et al.
Plos One|December 31, 2009
F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infectionJoão V Cordeiro, Susana Guerra, Yoshiki Arakawa, et al.
Plos One|December 17, 2011
Host-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 proteinSusana Guerra, Fernando Abaitua, Luis Martínez-Sobrido, et al.
Genes & Development|January 5, 2006
Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKRIván Ventoso, Miguel Angel Sanz, Susana Molina, et al.
Pageof 26

Showing results (41-50 of 256) with videos related to

Sort By:
Pageof 26
The Journal of Biological Chemistry|April 15, 2006
Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosisSusana Guerra, Luis A López-Fernández, María Angel García, et al.
Infection and Immunity|July 26, 2005
Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasisBlaise Dondji, Eva Pérez-Jimenez, Karen Goldsmith-Pestana, et al.
Journal of Virology|October 26, 2007
Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infectionsElena Domingo-Gil, Eva Pérez-Jiménez, Iván Ventoso, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 8, 2019
Pregestational body mass index, trimester-specific weight gain and total gestational weight gain: how do they influence perinatal outcomes?Isabel Gonzalez-Ballano, Ricardo Saviron-Cornudella, Luis Mariano Esteban, et al.
Plos One|February 3, 2015
Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigenMaria L Knudsen, Karl Ljungberg, Roger Tatoud, et al.
Plos One|July 9, 2010
Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigensJosé Luis Nájera, Carmen Elena Gómez, Juan García-Arriaza, et al.
Viruses|December 28, 2017
Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling PathwaysCarmen Elena Gómez, Beatriz Perdiguero, Cristina Sánchez-Corzo, et al.
Plos One|December 31, 2009
F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infectionJoão V Cordeiro, Susana Guerra, Yoshiki Arakawa, et al.
Plos One|December 17, 2011
Host-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 proteinSusana Guerra, Fernando Abaitua, Luis Martínez-Sobrido, et al.
Genes & Development|January 5, 2006
Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKRIván Ventoso, Miguel Angel Sanz, Susana Molina, et al.
Pageof 26